ID

39201

Beskrivning

Effectiveness and Patient Self-assessed Compliance of Blood Pressure Treatment With Tarka® Fixed Combination in Patients With Essential Hypertension; ODM derived from: https://clinicaltrials.gov/show/NCT01127139

Länk

https://clinicaltrials.gov/show/NCT01127139

Nyckelord

Versioner (1)
  1. 2019-12-10 2019-12-10 -
Rättsinnehavare

See clinicaltrials.gov

Uppladdad den

10 december 2019

DOI

För en begäran logga in.

Licens

Creative Commons BY 4.0
Modellkommentarer :

Här kan du kommentera modellen. Med hjälp av pratbubblor i Item-grupperna och Item kan du lägga in specifika kommentarer.

Tillbaka till modellkommentarer
Itemgroup-kommentar för :

Item-kommentar för :

Du måste vara inloggad för att kunna ladda ner formulär. Var vänlig logga in eller registrera dig utan kostnad.

Eligibility Essential Hypertension NCT01127139

Engelsk

Eligibility Essential Hypertension NCT01127139

1 Formulär  
Inclusion Criteria
Beskrivning

Inclusion Criteria

Alias
UMLS CUI
C1512693
men, women more than 18 years
Beskrivning

Age

Datatyp

boolean

Alias
UMLS CUI [1]
C0001779
patients with uncontrolled essential hypertension eligible to tarka treatment according to local label (bp ≥ 140/90 mmhg)
Beskrivning

Essential Hypertension Uncontrolled | Eligibility Tarka Therapy | Blood pressure determination

Datatyp

boolean

Alias
UMLS CUI [1,1]
C0085580
UMLS CUI [1,2]
C0205318
UMLS CUI [2,1]
C1548635
UMLS CUI [2,2]
C0595471
UMLS CUI [2,3]
C0087111
UMLS CUI [3]
C0005824
patients providing oral informed consent (including consent of their medical data to be used for a post marketing observational study) and cooperating with physician
Beskrivning

Informed Consent | Consent Use of Patient data | Compliance behavior

Datatyp

boolean

Alias
UMLS CUI [1]
C0021430
UMLS CUI [2,1]
C1511481
UMLS CUI [2,2]
C1524063
UMLS CUI [2,3]
C2707520
UMLS CUI [3]
C1321605
patients who never received tarka® in the past
Beskrivning

Tarka Absent In the past

Datatyp

boolean

Alias
UMLS CUI [1,1]
C0595471
UMLS CUI [1,2]
C0332197
UMLS CUI [1,3]
C1444637
patients whom tarka® will be prescribed according to the labelled indication and dose
Beskrivning

Tarka Dosage prescribed

Datatyp

boolean

Alias
UMLS CUI [1,1]
C0595471
UMLS CUI [1,2]
C0178602
UMLS CUI [1,3]
C0278329
Exclusion Criteria
Beskrivning

Exclusion Criteria

Alias
UMLS CUI
C0680251
patients contraindicated for treatment of tarka® according to the local summary of product characteristics (smpc):
Beskrivning

Medical contraindication Tarka

Datatyp

boolean

Alias
UMLS CUI [1,1]
C1301624
UMLS CUI [1,2]
C0595471
hypersensitive to the active substances or to any of the inactive ingredients
Beskrivning

Hypersensitivity Investigational New Drugs | Hypersensitivity Investigational New Drugs inactive ingredient

Datatyp

boolean

Alias
UMLS CUI [1,1]
C0020517
UMLS CUI [1,2]
C0013230
UMLS CUI [2,1]
C0020517
UMLS CUI [2,2]
C0013230
UMLS CUI [2,3]
C1552019
with cardiogenic shock
Beskrivning

Shock, Cardiogenic

Datatyp

boolean

Alias
UMLS CUI [1]
C0036980
with second and third degree atrioventricular block - except in patients with a functioning artificial pacemaker
Beskrivning

Second degree atrioventricular block | Complete atrioventricular block | Exception Artificial cardiac pacemaker Present

Datatyp

boolean

Alias
UMLS CUI [1]
C0264906
UMLS CUI [2]
C0151517
UMLS CUI [3,1]
C1705847
UMLS CUI [3,2]
C0030163
UMLS CUI [3,3]
C0150312
with sick sinus syndrome - except in patients with a functioning artificial pacemaker
Beskrivning

Sick Sinus Syndrome | Exception Artificial cardiac pacemaker Present

Datatyp

boolean

Alias
UMLS CUI [1]
C0037052
UMLS CUI [2,1]
C1705847
UMLS CUI [2,2]
C0030163
UMLS CUI [2,3]
C0150312
with atrial fibrillation/flutter and concomitant wolff-parkinson-white syndrome
Beskrivning

Atrial Fibrillation | Atrial Flutter | Wolff-Parkinson-White Syndrome

Datatyp

boolean

Alias
UMLS CUI [1]
C0004238
UMLS CUI [2]
C0004239
UMLS CUI [3]
C0043202
with existing history of angioedema associated with administration of an ace inhibitor
Beskrivning

Angioedema Associated with Angiotensin-Converting Enzyme Inhibitors

Datatyp

boolean

Alias
UMLS CUI [1,1]
C0002994
UMLS CUI [1,2]
C0332281
UMLS CUI [1,3]
C0003015
with severe renal (creatinine clearance < 10 ml/min) or severe liver impairment (cirrhosis with ascites)
Beskrivning

Renal Insufficiency Severe | Creatinine clearance measurement | Hepatic impairment Severe | Liver Cirrhosis with Ascites

Datatyp

boolean

Alias
UMLS CUI [1,1]
C1565489
UMLS CUI [1,2]
C0205082
UMLS CUI [2]
C0373595
UMLS CUI [3,1]
C0948807
UMLS CUI [3,2]
C0205082
UMLS CUI [4,1]
C0023890
UMLS CUI [4,2]
C0332287
UMLS CUI [4,3]
C0003962
pregnant women, women of childbearing potential who are unwilling to use contraception
Beskrivning

Pregnancy | Childbearing Potential Contraceptive methods Unwilling

Datatyp

boolean

Alias
UMLS CUI [1]
C0032961
UMLS CUI [2,1]
C3831118
UMLS CUI [2,2]
C0700589
UMLS CUI [2,3]
C0558080
lactating women
Beskrivning

Breast Feeding

Datatyp

boolean

Alias
UMLS CUI [1]
C0006147
patients who have participated in clinical studies within the last month or who are currently enrolled in clinical studies
Beskrivning

Study Subject Participation Status | Clinical Trial

Datatyp

boolean

Alias
UMLS CUI [1]
C2348568
UMLS CUI [2]
C0008976
patients currently treated with other fixed antihypertensive combination
Beskrivning

Antihypertensive Agents Combination

Datatyp

boolean

Alias
UMLS CUI [1,1]
C0003364
UMLS CUI [1,2]
C0013162
Tillbaka till toppen

Similar models

Eligibility Essential Hypertension NCT01127139

1 Formulär
Name
Typ
Description | Question | Decode (Coded Value)
Datatyp
Alias
Item Group
C1512693 (UMLS CUI)
Age
Item
men, women more than 18 years
boolean
C0001779 (UMLS CUI [1])
Essential Hypertension Uncontrolled | Eligibility Tarka Therapy | Blood pressure determination
Item
patients with uncontrolled essential hypertension eligible to tarka treatment according to local label (bp ≥ 140/90 mmhg)
boolean
C0085580 (UMLS CUI [1,1])
C0205318 (UMLS CUI [1,2])
C1548635 (UMLS CUI [2,1])
C0595471 (UMLS CUI [2,2])
C0087111 (UMLS CUI [2,3])
C0005824 (UMLS CUI [3])
Informed Consent | Consent Use of Patient data | Compliance behavior
Item
patients providing oral informed consent (including consent of their medical data to be used for a post marketing observational study) and cooperating with physician
boolean
C0021430 (UMLS CUI [1])
C1511481 (UMLS CUI [2,1])
C1524063 (UMLS CUI [2,2])
C2707520 (UMLS CUI [2,3])
C1321605 (UMLS CUI [3])
Tarka Absent In the past
Item
patients who never received tarka® in the past
boolean
C0595471 (UMLS CUI [1,1])
C0332197 (UMLS CUI [1,2])
C1444637 (UMLS CUI [1,3])
Tarka Dosage prescribed
Item
patients whom tarka® will be prescribed according to the labelled indication and dose
boolean
C0595471 (UMLS CUI [1,1])
C0178602 (UMLS CUI [1,2])
C0278329 (UMLS CUI [1,3])
Item Group
C0680251 (UMLS CUI)
Medical contraindication Tarka
Item
patients contraindicated for treatment of tarka® according to the local summary of product characteristics (smpc):
boolean
C1301624 (UMLS CUI [1,1])
C0595471 (UMLS CUI [1,2])
Hypersensitivity Investigational New Drugs | Hypersensitivity Investigational New Drugs inactive ingredient
Item
hypersensitive to the active substances or to any of the inactive ingredients
boolean
C0020517 (UMLS CUI [1,1])
C0013230 (UMLS CUI [1,2])
C0020517 (UMLS CUI [2,1])
C0013230 (UMLS CUI [2,2])
C1552019 (UMLS CUI [2,3])
Shock, Cardiogenic
Item
with cardiogenic shock
boolean
C0036980 (UMLS CUI [1])
Second degree atrioventricular block | Complete atrioventricular block | Exception Artificial cardiac pacemaker Present
Item
with second and third degree atrioventricular block - except in patients with a functioning artificial pacemaker
boolean
C0264906 (UMLS CUI [1])
C0151517 (UMLS CUI [2])
C1705847 (UMLS CUI [3,1])
C0030163 (UMLS CUI [3,2])
C0150312 (UMLS CUI [3,3])
Sick Sinus Syndrome | Exception Artificial cardiac pacemaker Present
Item
with sick sinus syndrome - except in patients with a functioning artificial pacemaker
boolean
C0037052 (UMLS CUI [1])
C1705847 (UMLS CUI [2,1])
C0030163 (UMLS CUI [2,2])
C0150312 (UMLS CUI [2,3])
Atrial Fibrillation | Atrial Flutter | Wolff-Parkinson-White Syndrome
Item
with atrial fibrillation/flutter and concomitant wolff-parkinson-white syndrome
boolean
C0004238 (UMLS CUI [1])
C0004239 (UMLS CUI [2])
C0043202 (UMLS CUI [3])
Angioedema Associated with Angiotensin-Converting Enzyme Inhibitors
Item
with existing history of angioedema associated with administration of an ace inhibitor
boolean
C0002994 (UMLS CUI [1,1])
C0332281 (UMLS CUI [1,2])
C0003015 (UMLS CUI [1,3])
Renal Insufficiency Severe | Creatinine clearance measurement | Hepatic impairment Severe | Liver Cirrhosis with Ascites
Item
with severe renal (creatinine clearance < 10 ml/min) or severe liver impairment (cirrhosis with ascites)
boolean
C1565489 (UMLS CUI [1,1])
C0205082 (UMLS CUI [1,2])
C0373595 (UMLS CUI [2])
C0948807 (UMLS CUI [3,1])
C0205082 (UMLS CUI [3,2])
C0023890 (UMLS CUI [4,1])
C0332287 (UMLS CUI [4,2])
C0003962 (UMLS CUI [4,3])
Pregnancy | Childbearing Potential Contraceptive methods Unwilling
Item
pregnant women, women of childbearing potential who are unwilling to use contraception
boolean
C0032961 (UMLS CUI [1])
C3831118 (UMLS CUI [2,1])
C0700589 (UMLS CUI [2,2])
C0558080 (UMLS CUI [2,3])
Breast Feeding
Item
lactating women
boolean
C0006147 (UMLS CUI [1])
Study Subject Participation Status | Clinical Trial
Item
patients who have participated in clinical studies within the last month or who are currently enrolled in clinical studies
boolean
C2348568 (UMLS CUI [1])
C0008976 (UMLS CUI [2])
Antihypertensive Agents Combination
Item
patients currently treated with other fixed antihypertensive combination
boolean
C0003364 (UMLS CUI [1,1])
C0013162 (UMLS CUI [1,2])
Tillbaka till toppen 

Kontakt

Använd detta formulär för feedback, frågor och förslag på förbättringar.

Fält markerade med * är obligatoriska.

Hjälp

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial